investorscraft@gmail.com

Intrinsic ValueChina Reinsurance (Group) Corporation (1508.HK)

Previous CloseHK$1.76
Intrinsic Value
Upside potential
Previous Close
HK$1.76

VALUATION INPUT DATA

This valuation is based on fiscal year data as of 2024 and quarterly data as of .

Data is not available at this time.

Stock Valuation Context

Business Model And Market Position

China Reinsurance (Group) Corporation is a dominant state-backed reinsurer operating primarily within the People's Republic of China, with a significant international footprint. Its core revenue model is built on assuming risk from primary insurers across a highly diversified portfolio, including property and casualty, life and health, and specialized lines like agriculture, aviation, and energy. The company leverages its scale and sovereign ownership to secure large treaty arrangements, while its asset management segment generates supplementary fee-based income. As a pillar of the Chinese financial system and a subsidiary of Central Huijin Investment, it holds a privileged market position, often acting as a mandatory cession for domestic risks. This entrenched role provides a stable, high-volume foundation, though it also creates a strategic dependency on the domestic regulatory environment and economic conditions. Its comprehensive service offerings, from traditional reinsurance to sophisticated risk consulting and investment management, position it as a full-service risk partner rather than just a capital provider.

Revenue Profitability And Efficiency

The group reported robust HKD 85.5 billion in revenue for the period, demonstrating its significant scale. Net income of HKD 10.6 billion reflects solid underlying profitability from its underwriting and investment activities. Operating cash flow of HKD 10.3 billion was strong and closely aligned with net income, indicating high earnings quality and efficient cash conversion from its core insurance operations.

Earnings Power And Capital Efficiency

Diluted earnings per share stood at HKD 0.25, providing a clear measure of per-share profitability. The company generated substantial operating cash flow that significantly exceeded its modest capital expenditures, highlighting a capital-light business model that efficiently converts premiums into cash. This strong cash generation supports both its investment strategies and its ability to meet policyholder obligations.

Balance Sheet And Financial Health

Financial health is underpinned by a strong liquidity position, with HKD 7.3 billion in cash and equivalents. Total debt of HKD 14.0 billion appears manageable for a financial institution of its size and is typical for supporting insurance float and investment leverage. The balance sheet reflects the conservative profile expected of a systemically important reinsurer.

Growth Trends And Dividend Policy

The company maintains a shareholder-friendly capital return policy, evidenced by a dividend per share of HKD 0.0548. This provides a yield for investors while retaining sufficient capital to support its insurance operations and strategic growth initiatives, both domestically and in its international expansion efforts.

Valuation And Market Expectations

With a market capitalization of approximately HKD 67.1 billion, the market values the company as a large-cap financial institution. A beta of 0.86 indicates that the stock is perceived as less volatile than the broader market, which is consistent with its status as a state-backed entity in a stable, regulated industry.

Strategic Advantages And Outlook

Its foremost strategic advantage is its sovereign ownership and role as a national reinsurer, ensuring a steady flow of domestic cessions. The outlook is tied to the growth of China's insurance market and the company's ability to prudently underwrite risks and manage its large investment portfolio amidst economic cycles and regulatory changes.

Sources

Company DescriptionFinancial Data Provided

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year2025202620272028202920302031203220332034203520362037203820392040204120422043204420452046204720482049

INCOME STATEMENT

Revenue growth rate, %NaN
Revenue, $NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $mNaN
Operating income, $mNaN
EBITDA, $mNaN
Interest expense (income), $mNaN
Earnings before tax, $mNaN
Tax expense, $mNaN
Net income, $mNaN

BALANCE SHEET

Cash and short-term investments, $mNaN
Total assets, $mNaN
Adjusted assets (=assets-cash), $mNaN
Average production assets, $mNaN
Working capital, $mNaN
Total debt, $mNaN
Total liabilities, $mNaN
Total equity, $mNaN
Debt-to-equity ratioNaN
Adjusted equity ratioNaN

CASH FLOW

Net income, $mNaN
Depreciation, amort., depletion, $mNaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $mNaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $mNaN
Free cash flow, $mNaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $mNaN
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount